A Digital Publication for the Practicing Medical Specialist, Industry Executive & Investor

Dan McCoy MD Named Chief Medical Officer at Catapult Health

Catapult’s forward-looking innovation and leadership in virtual clinical care were key drivers in bringing McCoy and Michel together

Dan McCoy MD will provide clinical and strategic leadership to the company as he joins Catapult’s executive team.

Dr. McCoy is a physician, entrepreneur, and communicator who is passionate about improving the way healthcare is delivered. In his time as president of Blue Cross and Blue Shield of Texas, he was instrumental in the creation of the C1 Innovation Lab in Dallas, with the goal of uniting clinicians, members, advocates, and innovators to work together to generate solutions. Dr. McCoy’s previous roles at BCBSTX included divisional senior vice president of the Texas market strategy, and Texas plan chief medical officer. During his term as president (2016-2020), BCBSTX experienced the largest growth in membership, underwriting margin and revenue in the company’s 90-year history.

“I’m excited about the opportunity to contribute to the already great work of Catapult Health,” said Dr. McCoy. “I’ve watched them from their early days and have always been impressed with how well they’ve focused on the patient, while being nimble and responsive to major changes in the healthcare environment.”

“I’ve known and worked with Dr. McCoy for the better part of a decade, and now is the perfect time for him to join our team,” said Michel. “Over the past year, we created and launched the nation’s first VirtualCheckup®, leveraging our world-class clinical expertise, sophisticated technology, and ability to scale up quickly. Dr. McCoy’s skills and experiences are very well matched with our go-forward strategy.”

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

The Evolut ™ FX+ TAVR system leverages market-leading valve performance with addition of larger windows to facilitate coronary access
The study was an analysis of AstraZeneca’s Phase 2 52-Week clinical trial of tralokinumab in patients with Idiopathic Pulmonary Fibrosis (IPF). The patient data from the trial was processed with Brainomix’s e-Lung tool. The tool is uniquely powered by the weighted reticulovascular score (WRVS), a novel biomarker that incorporates reticular opacities and vascular structures of the lung.
“Since the algorithm for matching patients with donors is changing across for all organs, this was a prime time to better understand whether transplant team decisions to accept a donated organ varied by patient race and gender,” she said. “We wanted to understand how the process of receiving a transplant after listing varied by race and gender, and the combination of the two, so that steps can be taken to make that process more equitable," said Khadijah Breathett, MD.
The Mount Sinai study found that primary care physicians’ approach reflects a dearth of evidence-based guidance for lung cancer screening shared decision-making in patients with complex comorbidities
This is the first ever transplantation of a genetically engineered porcine kidney into a living human recipient.

By using this website you agree to accept Medical Device News Magazine Privacy Policy